Last updated on March 2019

A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group Trial Evaluating the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults with Attention-deficit/Hyperactivity Disorder (Trial 405-201-00014)


Brief description of study

Centanafadine is being studied as a possible treatment for Attention-deficit/ Hyperactivity Disorder (ADHD).

 

Clinical Study Identifier: TX216179

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.